(Alliance News) - Hedge fund Citadel has made a GBP305 million bet against pharmaceuticals firm GSK PLC, the biggest short position against the company in more than a decade, according to the ...

Citadel, the hedge fund owned by billionaire Ken Griffin, has taken a short position in GlaxoSmithKline (NYSE:GSK), a British ...

But there are indications that large swaths of corporate America are already beginning to sour on Trump, as concerns grow ...

Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK , the Financial Times ...

Hedge fund Citadel has made a £305mn bet against drugmaker GSK, the biggest short position against the company in more than a decade.

The Citadel founder says that the US will lose out on international trade and the AI arms race as a result.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/106.Ckjk1Vbt.js ...

The wide range and uneven application of import tariffs by President Donald Trump is causing unease among consumers and ...

Citadel CEO Ken Griffin spoke out at the UBS Financial Services conference in Key Biscayne, Fla. on Tuesday, thanking Elon ...

Leading executives have largely avoided criticizing Trump and his plans. It’s reasonable to question, however, whether that’s ...

Griffin, who voted for Trump but did not donate to his campaign, believes the president's "bombastic rhetoric" on tariffs is ...

Ken Griffin, founder of investment firm Citadel, warned Tuesday that President Donald Trump's tariff policies pose a serious ...